CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines

Last updated: September 28, 2017
Project Number: RA0934-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical effectiveness of integrated cessation programs in adults who smoke cannabis and tobacco?
  2. What are the evidence-based guidelines associated with the use of integrated cessation programs in adults who smoke cannabis and tobacco?

Key Message

One systematic review with meta-analysis and one randomized controlled trial were identified regarding the clinical effectiveness of integrated cessation programs in adults who smoke cannabis and tobacco.